Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × STAMP-I protocol × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Agnosia 1

Interventions

Acetaminophen 2 engage 8200 1 Transdermal Patch 1 Telemedicine 1 STAMP-I protocol 1 Radiofrequency Ablation 1 Palliative Care 1 Oxycodone 1 Methods 1 Ketorolac 1 Ketoprofen 1 Ketamine 1 Electroencephalography 1 Dexmedetomidine 1 Cryosurgery 1 Capsaicin 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06117709 2026-03-19

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

Dana-Farber Cancer Institute

Phase NA Not yet recruiting

Agnosia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡